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Abstract 
Purpose: COVID-19 pandemic recovery will require a broad and coordinated effort for infection 
testing, immunity determination, and vaccination. With the advent of several COVID-19 
vaccines, the dissemination and delivery of COVID-19 immunization across the nation is of 
concern. Previous immunization delivery patterns may reveal important components of a 
comprehensive and sustainable effort to immunize everyone in the nation.  
Methods: The delivery of vaccinations were enumerated by provider type using 2017 Medicare 
Part B Fee-For-Service data and the 2013-2017 Medical Expenditure Panel Survey. The delivery 
of these services was examined at the service, physician, and visit level. 
Results: In 2017 Medicare Part B Fee-For-Service, Primary Care Physicians provided the largest 
share of services for vaccinations (46%), followed closely by Mass Immunizers (45%), then 
NP/PAs (5%). The Medical Expenditure Panel Survey showed that Primary Care Physicians 
provided most clinical visits for vaccination (54% of all visits).  
Conclusions: Primary Care Physicians have played a crucial role in delivery of vaccinations to 
the U.S. population, including the elderly, between 2012-2017. These findings indicate primary 
care practices may be a crucial element of vaccine counseling and delivery in the upcoming 
COVID-19 recovery and immunization efforts in the United States. 
Introduction 
While the COVID-19 pandemic continues to wax and wane throughout the country, 
efforts must combine the best pandemic response with preparation for pandemic recovery. 
Experts have called for widespread testing, contact tracing, and case isolation as preconditions 
for safely reopening schools, lifting activity restrictions, and preventing future COVID-19 
resurgence.
1,2
 Scientific knowledge of the immunity conferred by antibodies developed by
infection with COVID-19 is evolving, but public health experts agree that herd immunity from 
infection is an unreasonable approach to tackling the pandemic.
3,4,5
 The arrival of  safe and
effective vaccines brings hope and may alleviate some of the complexities related to testing and 
treatment.
6,7,8
An important step towards recovery from COVID-19 is the mass distribution of a 
vaccine.
9,10,11,12
 While much attention has been on the development and manufacturing of a novel
SARS-CoV-2 vaccine, it is now clear that the distribution and delivery also require careful 
planning.
13
 Many reports highlight the role of large chain pharmacies to deliver the COVID-19
vaccine. Complex and expensive shipping and storage requirements of the first approved vaccine 
require detailed planning. Additional vaccines entering the market may eliminate many of these 
more complex storage requirements. Access to the vaccination in large population centers as well 
as remote rural areas will require use of current and novel networks to reach adequate herd 
immunity levels.  
Even if the United States is able to appropriately deliver the COVID-19 vaccine to all 
communities, vaccine hesitancy may slow herd immunity. A recent Kaiser Family Foundation 
survey found that over a quarter of adults in the United States are hesitant to get the COVID-19 
vaccine, and this proportion is much higher in certain populations and geographies.
14
 Without
appropriate counseling about the vaccine, the potential for recovery is hampered. Surveys have 
shown that the most trusted source of information on the COVID-19 and other vaccines is a 
patient’s own doctor or healthcare provider.
15
 But no studies, to our knowledge, have quantified
where patients have historically received their vaccines.  
This study examines the role of primary care physicians and other providers in delivering 
vaccinations in the United States. We used two main datasets to create an in-depth analysis of 
services delivered to the Medicare Part B Fee-For-Service (FFS) beneficiary population, 
followed by analysis of the Medical Expenditure Panel Survey to determine delivery patterns for 
immunizations among all age groups. The combination of these two datasets provides a robust 
analysis of a representative sample of adults of all ages living in the United States. Historic 
immunization delivery patterns may shed light on provider capacity for rapid deployment of 
COVID-19 vaccine counseling and delivery. 
Methods 
Medicare Fee-For-Service 
This study uses Centers for Medicare and Medicaid Services (CMS) 2017 Medicare 
Provider Utilization and Payment Data: Physician and Other Supplier Public Use File (PUF) and 
CMS National Plan and Provider Enumeration System (NPPES) August 2017 Quarter 3 Update. 
The Physician and Other Supplier PUF includes services provided to beneficiaries enrolled in 
Medicare Part B FFS in 2017 at the provider level. We linked the data files using National 
Provider Identifier (NPI) and geocoded providers’ addresses at the county level using NPPES. 
We calculated vaccination services by provider type and county. We categorized Primary Care 
Physicians (PCPs) in the Medicare PUF using the standard method that includes Family Practice, 
General Practice, Geriatric Medicine, or Internal Medicine. “Mass Immunizers” include 
drugstore and grocery chains as well as community pharmacies and were identified using the 
provider terms of Centralized Flu, Mass Immunizer Roster Biller, Pharmacy, or Public Health or 
Welfare Agency. The Medicare PUF does not differentiate internal medicine physicians that are 
specialists from those that practice general internal medicine. The Medicare PUF includes non-
physician provider types of Physician Assistant (PA), Nurse Practitioner (NP), and Certified 
Clinical Nurse Specialist, but does not provide specialty of PAs or NPs. 
We used Healthcare Common Procedure Coding System (HCPCS) code descriptions to 
identify services in the Medicare PUF. To be included as a vaccination service, the description 
must have contained “vaccine” or “vaccination” and not have contained “detection” (Appendix 
Table 1). 
Medical Expenditure Panel Survey 
We merged medical conditions, office-based, outpatient and consolidated files from the 
Medical Expenditure Panel Survey (MEPS) to enumerate services delivered in office-based and 
outpatient visits in 2013 through 2017. We used multiple years to assure adequate sample size. 
MEPS provides nationally representative estimates of health care services and expenditures for 
adults of all ages. We used questions related to reasons for visit from the office-based and 
outpatient files to identify visits for vaccination (Online supplemental Appendix Table 2). We 
included physicians with specialties of Family Medicine, Internal Medicine, Pediatrics, and 
Geriatrics in the PCP category in MEPS. We calculated the number and proportion of visits for 
vaccinations seen by PCPs, NP/PAs and other non-physician providers using survey weights 
averaged over the five years pooled from 2013-2017 which result in a nationally representative 
sample for one year. 
A Medicare “service” is a unique billing code, and a clinical encounter might include 
multiple “services.” While MEPS uses different terminology for clinical care (visit, encounter, 
service), we used the term “visit” to represent any clinical encounter that included a vaccination. 
For MEPS, these visits might include multiple services, but each visit is only counted once. We 




There were over 2.4 billion services included in the 2017 Medicare Physicians and Other 
Supplier PUF including nearly 34.3 million vaccinations (Table 1). There were 1,032,911 unique 
clinical providers of which 150,894 (15%) delivered vaccinations. Overall, PCPs provided the 
most vaccinations (46%), followed closely by Mass Immunizers (45%), then NP/PAs (5%). 
An examination of vaccinations at the county level showed that PCPs administered 
between 25-50% of vaccinations in the majority of counties in Medicare Part B FFS in 2017. 
Additionally, there were clusters of counties that had over 50% of vaccinations provided by 
PCPs throughout states such as Louisiana, Pennsylvania, and Massachusetts. (Online 
supplemental Appendix Figure 1.)  
Medical Expenditure Panel Survey 
There were an average 69.7 million vaccination visits in office-based settings in the U.S. 
per year, according to the 2013-2017 MEPS (Table 2). The majority of visits for vaccinations 
were with PCPs (53.6%).  
Discussion 
Historically, primary care practice has played an important role in vaccine delivery.  
Because many patients have received their vaccines from their primary care practice, these same 
practices may play a crucial role in the COVID-19 immunization dissemination and delivery. 
Whether primary care physicians provide the vaccine, or only provide immunization counseling, 
their role may help assure successful delivery of the COVID-19 vaccines to communities across 
the nation, including rural and remote communities. In addition to physically administering 
vaccinations, PCPs can provide clinical and personal support to enable patients to understand 
their current COVID-19 immunologic status, how that may impact their vaccine decisions, and 
to counter vaccine hesitancy and misinformation.
16 
 Manufactures already deliver vaccines and
Medicare has individual provider and practice billing information for primary care practices that 
provide vaccines, therefore, a distribution list is ready-made. Using the current vaccine delivery 
in primary care may greatly improve COVID-19 vaccine distribution.    
Given the political nature of the COVID-19 pandemic, including the vaccine 
development and approval process, there is a high level of distrust in the COVID-19 vaccine.
17
The new vaccines may face more vaccine hesitancy, misinformation, and refusal than other 
vaccines. Primary care physicians are often considered a trusted source of medical information. 
And based on the historic immunization data, are evidently a trusted source for vaccine 
information. In addition to delivering the actual vaccine, primary care practices may play an even 
more important role in vaccine counseling, building local community trust, and serving as a 
source of scientific knowledge about the COVID-19 vaccine. 
The COVID-19 pandemic has not affected all populations equally - the Medicare Fee-
For-Service (FFS) beneficiary population, comprised of over 40 million people who are mostly 
65 and over, is disproportionately at risk for complication and death due from COVID-19.
17,18
Delivering vaccinations to this older population is essential for mitigating the most devastating 
consequences of the virus. Closer examination of the provision of these services by patient race 
and ethnicity, while beyond the scope of this paper, is also critical, as the COVID-19 pandemic 
has disproportionately affected Black, Latino, and Indigenous Americans,
 
who also experience 
lower rates of vaccination and higher likelihoods of concurrent COVID-19 risk factors.
19,20,21,22,23
The Medicare PUF used in this study does not allow for the identification of the 
originating provider who may have referred to a mass immunizer or other facility for 
vaccination. Additionally, the Medicare PUF limits aggregation of services to providers with 10 
or more beneficiaries per HCPCS code. Further, the use of county-level data does not account for 
beneficiaries who traveled across counties to receive a service.  
The Medical Expenditure Panel Survey is based on self-reported patient data and is 
subject to recall bias; however, a third of the sample is validated using a sample of providers and 
delivery sites. Its non-institutionalized civilian population sample may not reflect the vaccination 
rates of the entire U.S. population. MEPS is widely used and considered a reliable source for 
health services research. 
None of the datasets allow for differentiating specialist internal medicine from general 
internal medicine, nor do they provide the level of detail necessary to determine specialty of 
NP/PAs or if NP/PAs may have been ordering immunizations but billing under a physician code. 
In addition, NPs could not be distinguished from nurses since MEPS groups these clinicians into 
a single category. Therefore, these data may overestimate the contribution of vaccination by 
general internal medicine and underestimate the contribution of vaccination by NP/PAs.  
Primary care physicians deliver preventive care as well as address acute and chronic 
medical needs. They are equipped to provide clinical guidance to help patients interpret results 
from COVID-19 testing and immunity determinations and answer vaccine questions.  Given its 
historic role in immunization counseling and vaccine delivery, primary care, in concert with 
public health agencies and community health organizations, is essential for immediate and 
sustainable population health efforts to address COVID-19 recovery.  
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Tables, Figures and Appendices 
Table 1. Medicare Part B Fee-For-Service Billable Services and Vaccinations by Provider Type, 
2017 
Provider Type 
Total Number  
of Services 
Unique Providers Vaccination Unique Vaccine Providers 
n % n % n % n % 
Mass Immunizer 15,476,697 0.6 40,246 3.9 15,474,448 45.2 40,242 26.7 
Centralized Flu 6,382,129 0.3 9,793 1.0 6,382,129 18.6 9,793 6.5 
Mass Immunizer 
Roster Biller 
8,979,771 0.4 30,144 2.9 8,978,511 26.2 30,142 20.0 
Pharmacy 7,484 0.0 29 0.0 6,564 0.0 27 0.0 
Public Health or 
Welfare Agency 
107,313 0.0 280 0.0 107,244 0.3 280 0.2 
Primary Care 
Physician 
315,693,224 13.1 183,475 17.8 15,834,619 46.2 77,627 51.4 
Family Practice 122,477,653 5.1 81,809 7.9 7,704,970 22.5 41,777 27.7 
General Practice 6,989,241 0.3 4,943 0.5 198,196 0.6 1,264 0.8 
Geriatric Medicine 2,442,902 0.1 1,811 0.2 87,031 0.3 478 0.3 
Internal Medicine 183,783,428 7.6 94,912 9.2 7,844,422 22.9 34,108 22.6 
NP/PA/CCNS 102,676,780 4.3 171,180 16.6 1,592,519 4.7 20,861 13.8 
Certified Clinical 
Nurse Specialist 
949,837 0.0 1,979 0.2 3,897 0.0 40 0.0 
Nurse Practitioner 63,649,600 2.6 104,098 10.1 1,198,546 3.5 15,391 10.2 
Physician Assistant 38,077,343 1.6 65,103 6.3 390,076 1.1 5,430 3.6 
Clinical Laboratory 314,641,419 13.1 2,838 0.3 126 0.0 3 0.0 
Other 1,662,710,608 69.0 635,172 61.5 1,364,870 4.0 12,161 8.1 
Total 2,411,198,729 100 1,032,911 100 34,266,581 100 150,894 100 
Source: Centers for Medicare and Medicaid Services Medicare Provider Utilization and Payment 
Data: Physician and Other Supplier Public Use, 2017; Centers for Medicare and Medicaid 
Services National Provider Payment Enumeration System, August 2017 Quarter 3 Update. 
Table 2. Vaccination Visits by Provider Type in Medical Expenditure Panel Survey, 2013-2017 
Provider Type 
Vaccination Visits 
n (Weighted) % 
Primary Care Physicians 37,332,602 53.6 
Family Medicine      13,618,734      19.5 
Internal Medicine        2,971,356        4.3 
Pediatrics      20,664,522      29.6 
Geriatrics 77,990        0.1 
NP/PA 15,584,875 22.4 
Non-Primary Care Physician 7,859,141 11.3 
Other Non-Physician 8,934,141 12.8 
Total 67,299,316 100 
Source: Medical Expenditure Panel Survey, 2013-2017 
Appendix 1 – Supplemental Material. (For inclusion as online supplemental material.) 
Appendix - Figure 1. Percent of Medicare Fee-For-Service Blood Tests and Vaccinations by 
Primary Care Physicians, 2017 
 Source: Centers for Medicare and Medicaid Services Medicare Provider Utilization and 
Payment Data: Physicians and Other Supplier Public Use File, 2017; Centers for Medicare and 
Medicaid Services National Provider Payment Enumeration System, August 2017 Quarter 3 
Update. 
PCP: Primary Care Physician. 
Appendix - Table 1. Healthcare Common Procedure Coding System Codes Used to Identify 
Services in CMS Medicare Provider Utilization and Payment Data: Physician and Other Supplier 
Public Use, 2017 
Service Type Healthcare Common Procedure Coding System Codes 
Vaccination 
90460, 90471, 90472, 90630, 90632, 90654, 90662, 90668, 90670, 
90672, 90673, 90685, 90686, 90697, 90714, 90715, 90732, 90740, 
90746, 90747, 90749, G0008, G0009, G0010, Q2034, Q2035, Q2036, 
Q2037, Q2038, Q2039 
Appendix - Table 2. ICD-9 Codes, ICD-10 Codes, and Medical Provider Questions Used to 
Identify Services in Medical Expenditure Panel Survey, 2013-2017 
Service Type 
ICD-9 Codes         
(2013-2015) 
ICD-10 Codes         
(2016-2017) 





"This visit, did patient receive 
an immunization?" 
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